Science and Research

Objectively measured physical activity as a COPD clinical trial outcome

BACKGROUND: Reduced physical activity is common in COPD and is associated with poor outcomes. Physical activity is therefore a worthy target for intervention in clinical trials, however, trials evaluating physical activity have used heterogeneous methodologies. RESEARCH QUESTION: What is the available evidence on the efficacy and/or effectiveness of various interventions to enhance objectively measured physical activity in patients with COPD, taking into account minimal preferred methodological quality of physical activity assessment? STUDY DESIGN AND METHODS: In this narrative review, the COPD Biomarker Qualification Consortium (CBQC) task force searched three scientific databases for articles that reported the effect of an intervention on objectively-measured physical activity in COPD. Based on scientific literature and expert consensus, only studies with ≥7 measurement days and ≥4 valid days of ≥8 hours of monitoring were included in the primary analysis. RESULTS: 37 of 110 (34%) identified studies fulfilled the criteria, investigating the efficacy and/or effectiveness of physical activity behavior change programs (n=7), mobile health or eHealth interventions (n=9), rehabilitative exercise (n=9), bronchodilation (n=6), lung volume reduction procedures (n=3) and other interventions (n=3). Results are generally variable, reflecting the large variation in study characteristics and outcomes. Few studies show an increase beyond the proposed minimal important change of 600-1100 daily steps, indicating that enhancing physical activity levels is a challenge. INTERPRETATION: Only a third of clinical trials measuring objective physical activity in people with COPD fulfilled the pre-set criteria regarding physical activity assessment. Studies showed variable effects on physical activity even when investigating similar interventions.

  • Burtin, C.
  • Mohan, D.
  • Troosters, T.
  • Watz, H.
  • Hopkinson, N. S.
  • Garcia-Aymerich, J.
  • Moy, M. L.
  • Vogiatzis, I.
  • Rossiter, H. B.
  • Singh, S.
  • Merrill, D. D.
  • Hamilton, A.
  • Rennard, S. I.
  • Fageras, M.
  • Petruzzelli, S.
  • Tal-Singer, R.
  • Tomaszewski, E.
  • Corriol-Rohou, S.
  • Rochester, C. L.
  • Sciurba, F. C.
  • Casaburi, R.
  • D. C. Man W
  • Van Lummel, R. C.
  • Cooper, C. B.
  • Demeyer, H.
  • Spruit, M. A.
  • Vaes, A.
Publication details
DOI: 10.1016/j.chest.2021.06.044
Journal: Chest
Work Type: Review
Location: Assoziierter Partner
Disease Area: COPD
Partner / Member: PRI
Access-Number: 34217679

DZL Engagements

chevron-down